Submit Deal

ON TARGET LABORATORIES

Summary

On Target Laboratories is a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 24 M

Avg. Deal Size£ 24 M

Market Context

Senior Management

Ben Lundgren
President and CEO

Sort

16 Nov 2023|United States|Biotechnology

Target: ON TARGET LABORATORIES

Bidder: PENSION FUND OF THE CHRISTIAN CHURCH

4 Service Providers

2 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 24 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy